Targeting N4-acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2-mediated HMGB2 mRNA translation.

Hailing Liu <a class=“affiliation-link” title=“Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China.” href=“https://pubmed.ncbi.nlm.nih.gov/39030964#full-view-affiliation-1" …